Delivery Order SPE2DB20D2104-SPE2DB26FMAUA
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count units) on September 26, 2025, with a ceiling value of $3,626.64 and completion deadline of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,790.82 to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg, a prescription antiplatelet medication used to reduce cardiovascular events in patients with acute coronary syndrome. Issued on April 23, 2025, with an ultimate completion date of April 24, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,094.77 to AmerisourceBergen Drug Corp for 60 tablets of BRILINTA 60 mg, with a completion deadline of September 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.13 to AmerisourceBergen Drug Corp for 60 tablets of BRILINTA 90 mg, a prescription antiplatelet medication used to reduce cardiovascular events in patients with acute coronary syndrome. The contract employs firm fixed price terms with an ultimate completion date of June 9, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $3,329.04. The delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets in a quantity of 60 units, valued at $3,159.11. This competitively awarded, non-set-aside contract was executed on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizing firm fixed price terms. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,335.32 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 MG tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on June 6, 2025, with an ultimate completion date of June 9, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of BRILINTA 60 mg tablets (quantity 60s) with a ceiling value of $6,438.32. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,303.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on June 20, 2025, with completion scheduled for June 23, 2025. This competitive award, made without a set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product...